Haig G
Curr Med Res Opin. 1988;10(10):645-51. doi: 10.1185/03007998809111113.
Thirty patients suffering from strains, sprains or direct soft tissue injuries were entered into a double-blind trial comparing mefenamic acid and piroxicam. Mefenamic acid was given at a dosage of 500 mg 3-times daily and piroxicam as a single daily dose of 20 mg, for a maximum of 10 days. Both drugs were effective in treating the symptoms associated with acute soft tissue injuries. There were statistically significant improvements in all parameters monitored (pain, functional capacity, sleep disturbance, local swelling and tenderness) by Day 2, except for local swelling in the mefenamic acid group and sleep disturbance in the piroxicam group. By Day 5 all parameters showed improvement. Almost all (90%) of the patients had recovered from their injury in less than 1 week. Both drugs were well tolerated, only 5 patients reporting adverse events (3 on mefenamic acid and 2 on piroxicam).
30名患有拉伤、扭伤或直接软组织损伤的患者参与了一项比较甲芬那酸和吡罗昔康的双盲试验。甲芬那酸的给药剂量为每日3次,每次500毫克;吡罗昔康的给药剂量为每日单次20毫克,最长给药10天。两种药物在治疗急性软组织损伤相关症状方面均有效。到第2天,除甲芬那酸组的局部肿胀和吡罗昔康组的睡眠障碍外,所有监测参数(疼痛、功能能力、睡眠障碍、局部肿胀和压痛)均有统计学意义的改善。到第5天,所有参数均显示有所改善。几乎所有(90%)患者在不到1周的时间内从损伤中恢复。两种药物耐受性良好,只有5名患者报告了不良事件(3名使用甲芬那酸,2名使用吡罗昔康)。